StockWatch
·

CARE Ratings Ltd

BSE: 534804

P/L Snapshot

Q1 FY27 · standalone

vs Q4 FY26·vs Q1 FY26
Revenue
103.79
-15.6%+14.8%
Expenditure
58.75
+12.1%+15.2%
Net Profit
33.88
-36.5%+16.4%
OPM %
36.41%
-17.41pp+0.54pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.0035.5171.01106.52142.03Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Price Chart
Latest News
Board Meeting7 Aug, 6:00 pm

CARE Ratings Q1 FY27: PAT +25% YoY to ₹33 Cr, revenue +19%; QoQ fall is seasonal

CARE Ratings' consolidated revenue for Q1 FY27 (quarter ended June 30, 2026) came in at ₹111.68 Cr, up 18.9% YoY from ₹93.91 Cr, while consolidated net profit rose 24.5% YoY to ₹32.99 Cr (₹32.26 Cr attributable to owners) from ₹26.50 Cr, with basic EPS at ₹10.73 versus ₹8.61 a year ago. Sequentially, both lines fell sharply — revenue down 14.5% and PAT down 38.3% from Q4 FY26's ₹130.67 Cr / ₹53.45 Cr — but Q4 is seasonally CARE's strongest quarter as issuers rush bond and instrument ratings ahead of financial year-end, so the QoQ drop is a seasonality artifact rather than a deterioration; the YoY comparison is the more meaningful read. On a standalone basis, revenue grew 16.5% YoY to ₹88.15 Cr and PAT grew 16.4% YoY to ₹33.88 Cr — standalone PAT growth trails the consolidated 24.5% by roughly 8 points, a divergence driven by the non-ratings subsidiary bucket ("Others" segment) swinging to a small ₹0.14 Cr loss this quarter (from a ₹1.06 Cr profit in Q4 FY26) and ₹0.73 Cr of profit attributable to non-controlling interests being carved out at the consolidated level. Profitability grew faster than revenue YoY on modest operating leverage: consolidated operating margin (revenue less employee and other expenses) rose to 31.0% from 29.5% a year ago, and net margin (on total income) rose to 26.1% from 24.6%. The gain was tempered by other expenses jumping 43.2% YoY to ₹17.85 Cr (from ₹12.47 Cr) — the single largest cost driver — alongside a 10.2% YoY rise in employee costs to ₹59.20 Cr; there were no exceptional items in either the current or year-ago quarter, so both YoY comparisons are clean. Sequentially, margins compressed steeply (OPM from 46.5% to 31.0%, NPM from 36.5% to 26.1%) as employee costs rose a further 12.6% QoQ even as revenue fell — consistent with CARE's cost base staying largely fixed through the seasonal Q4-to-Q1 revenue step-down. By segment, the core ratings business (₹98.71 Cr, ~88% of revenue) grew 19.0% YoY but fell 16.1% QoQ on the same seasonal pattern, while the smaller non-ratings "Others" segment (₹13.51 Cr) grew a faster 22.9% YoY and was roughly flat QoQ (+1.9%), holding up better through the seasonal trough even as its own profitability dipped into a small loss. Management's prior (Q4 FY26) commentary was confident and optimistic, guiding to continued broad-based revenue and profit growth across ratings and non-ratings businesses through FY27 on operating leverage and disciplined execution, alongside a moderate GDP growth moderation to 6.7%; this quarter's double-digit YoY growth on both lines is broadly consistent with that framing, though there is no specific numeric target to grade a clean beat/miss against. No formal Street consensus estimate for this print turned up in a web search, so vsStreet is marked unknown rather than inferred, and there is no company press release accompanying this filing to cross-check management's own framing of the quarter. Corporate developments in the quarter were largely governance-related rather than operational: B S R & Co. LLP was re-appointed statutory auditor for a fresh five-year term (July 3, 2026), Sanjay Agarwal was appointed Chief Risk Officer (July 1, 2026), and the FY26 annual report/AGM notice went out ahead of the 33rd AGM — none of which bear directly on this quarter's P&L.

7 Aug 2026, 06:00 pm

Corporate Events

Board MeetingCARERATING
2026
7Aug

Board Meeting

The meeting of the Board of Directors is scheduled to consid…

BSE Filing
Board MeetingCARERATING
2026
3Jul

Board Meeting

The Members of the Company at the 33rd Annual General Meetin…

BSE Filing
Board MeetingCARERATING
2025
30Jan

Board Meeting

Intimation of Board Meeting, Consider and approve Unaudited …

BSE Filing
DividendCARERATING
2024
21Jun

₹11 / share

BSE Filing
Board MeetingCARERATING
2024
9May

Board Meeting

Consider and approve Audited (Standalone & Consolidated) Fin…

BSE Filing
Board MeetingCARERATING
2024
24Jan

Board Meeting

consider and approve Unaudited (Standalone & Consolidated) F…

BSE Filing
DividendCARERATING
2023
10Nov

₹7 / share

BSE Filing
Board MeetingCARERATING
2023
31Oct

Board Meeting

consider and approve the Unaudited (Standalone & Consolidate…

BSE Filing